Literature DB >> 34464680

The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.

Emily S Marques1, Juliana Agudelo1, Emily M Kaye1, Seyed Mohamad Sadegh Modaresi1, Marisa Pfohl1, Jitka Bečanová2, Wei Wei1, Marianne Polunas3, Michael Goedken3, Angela L Slitt4.   

Abstract

Per- and polyfluoroalkyl substances (PFAS) are a family of chemicals that are ubiquitous in the environment. Some of these chemicals, such as perfluorooctanesulfonic acid (PFOS), perfluorohexanesulfonate (PFHxS) and perfluorooctanoic acid (PFOA), are found in human sera and have been shown to cause liver steatosis and reduce postnatal survival and growth in rodents. The purpose of this work is to evaluate the impact of diet and PFAS exposure to mouse dam (mus musculus) on the risk to pup liver and metabolism endpoints later in life, as well as evaluate PFAS partitioning to pups. Timed-pregnant dams were fed a standard chow diet or 60 % kcal high fat diet (HFD). Dams were administered either vehicle, 1 mg/kg PFOA, 1 mg/kg PFOS, 1 mg/kg PFHxS, or a PFAS mixture (1 mg/kg of each PFOA, PFOS, and PFHxS) daily via oral gavage from gestation day 1 until postnatal day (PND) 20. At PND 21, livers of dams and 2 pups of each sex were evaluated for lipid changes while remaining pups were weaned to the same diet as the dam for an additional 10 weeks. Dam and pup serum at PND 21 and PND 90 were also evaluated for PFAS concentration, alanine aminotransferase (ALT), leptin and adiponectin, and glycosylated hemoglobin A1c. Perinatal exposure to a HFD, as expected, increased pup body weight, maternal liver weight, pup liver triglycerides, pup serum ALT, and pup serum leptin. PFOA and the PFAS mixture increased liver weights, and. treatment with all three compounds increased liver triglycerides. The maternal HFD increased dam and pup serum PFAS levels, however, was protective against PFOA-induced increase in serum ALT and observed increases in liver triglycerides. The PFAS mixture had very distinct effects when compared to single compound treatment, suggesting some cumulative effects, particularly when evaluating PFAS transfer from dam to pup. This data highlights the importance of diet and mixtures when evaluating liver effect of PFAS and PFAS partitioning.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liver; Mixtures; Perfluoroalkyl substances (PFAS); Perinatal

Mesh:

Substances:

Year:  2021        PMID: 34464680      PMCID: PMC8554779          DOI: 10.1016/j.tox.2021.152921

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.571


  87 in total

1.  Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Authors:  Adam J Filgo; Erin M Quist; Mark J Hoenerhoff; Amy E Brix; Grace E Kissling; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-11-14       Impact factor: 1.902

2.  Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys.

Authors:  Shu-Ching Chang; Patricia E Noker; Gregory S Gorman; Sheila J Gibson; Jill A Hart; David J Ehresman; John L Butenhoff
Journal:  Reprod Toxicol       Date:  2011-08-11       Impact factor: 3.143

Review 3.  A short review on human exposure to and tissue distribution of per- and polyfluoroalkyl substances (PFASs).

Authors:  Jun-Meng Jian; Da Chen; Fu-Juan Han; Ying Guo; Lixi Zeng; Xingwen Lu; Fei Wang
Journal:  Sci Total Environ       Date:  2018-05-03       Impact factor: 7.963

4.  The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.

Authors:  Xilin Li; Zemin Wang; James E Klaunig
Journal:  Toxicology       Date:  2019-01-31       Impact factor: 4.221

Review 5.  Renal elimination of perfluorocarboxylates (PFCAs).

Authors:  Xing Han; Diane L Nabb; Mark H Russell; Gerald L Kennedy; Robert W Rickard
Journal:  Chem Res Toxicol       Date:  2011-10-25       Impact factor: 3.739

6.  Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; Yi Weaver; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2017-03-01       Impact factor: 4.849

7.  PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport.

Authors:  H T Wan; Y G Zhao; X Wei; K Y Hui; J P Giesy; Chris K C Wong
Journal:  Biochim Biophys Acta       Date:  2012-03-28

8.  Polyfluoroalkyl chemicals in the serum and milk of breastfeeding women.

Authors:  Ondine S von Ehrenstein; Suzanne E Fenton; Kayoko Kato; Zsuzsanna Kuklenyik; Antonia M Calafat; Erin P Hines
Journal:  Reprod Toxicol       Date:  2009-03-06       Impact factor: 3.143

9.  Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation.

Authors:  Cynthia J Wolf; Cynthia V Rider; Christopher Lau; Barbara D Abbott
Journal:  Toxicology       Date:  2013-12-26       Impact factor: 4.221

10.  Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.

Authors:  Philippe Grandjean; Carsten Heilmann; Pal Weihe; Flemming Nielsen; Ulla B Mogensen; Esben Budtz-Jørgensen
Journal:  Environ Health Perspect       Date:  2017-07-26       Impact factor: 9.031

View more
  3 in total

Review 1.  Adverse Effects of Perfluorooctane Sulfonate on the Liver and Relevant Mechanisms.

Authors:  Pingwei Wang; Dongge Liu; Shuqi Yan; Jiajing Cui; Yujun Liang; Shuping Ren
Journal:  Toxics       Date:  2022-05-19

Review 2.  Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis.

Authors:  Elizabeth Costello; Sarah Rock; Nikos Stratakis; Sandrah P Eckel; Douglas I Walker; Damaskini Valvi; Dora Cserbik; Todd Jenkins; Stavra A Xanthakos; Rohit Kohli; Stephanie Sisley; Vasilis Vasiliou; Michele A La Merrill; Hugo Rosen; David V Conti; Rob McConnell; Leda Chatzi
Journal:  Environ Health Perspect       Date:  2022-04-27       Impact factor: 9.031

3.  Protracted Impairment of Maternal Metabolic Health in Mouse Dams Following Pregnancy Exposure to a Mixture of Low Dose Endocrine-Disrupting Chemicals, a Pilot Study.

Authors:  Alyssa K Merrill; Timothy Anderson; Katherine Conrad; Elena Marvin; Tamarra James-Todd; Deborah A Cory-Slechta; Marissa Sobolewski
Journal:  Toxics       Date:  2021-12-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.